Unfractionated heparin activity measured by anti-factor xa levels is associated with the need for extracorporeal membrane oxygenation circuit/membrane oxygenator change: A retrospective pediatric study

Pediatric Critical Care Medicine

Volumn 15, Issue 4, 2014, Pages

  Irby, Katherine ^a   Swearingen, Christopher ^a   Byrnes, Jonathan ^a   Bryant, Joshua ^b   Prodhan, Parthak ^a   Fiser, Richard ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b ARKANSAS CHILDREN S HOSPITAL   (United States)

Author keywords

Anti Factor Xa; Children; Extracorporeal membrane

Indexed keywords

ANTITHROMBIN III; BLOOD CLOTTING FACTOR 10A; FIBRINOGEN; HEPARIN; ANTICOAGULANT AGENT;

ADOLESCENT; ADULT; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TIME; CHILD; CIRCUIT MEMBRANE OXYGENATOR; CLINICAL FEATURE; DRUG DOSE TITRATION; EXTRACORPOREAL OXYGENATION; FEMALE; HUMAN; INFANT; INFUSION RATE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MEMBRANE OXYGENATOR; NEWBORN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; RETROSPECTIVE STUDY; BLOOD; DEVICES; METABOLISM; PRESCHOOL CHILD; PROCEDURES; THROMBOSIS; YOUNG ADULT;

ADOLESCENT; ANTICOAGULANTS; CHILD; CHILD, PRESCHOOL; EXTRACORPOREAL MEMBRANE OXYGENATION; FACTOR XA; FEMALE; HEPARIN; HUMANS; INFANT; INFANT, NEWBORN; MALE; RETROSPECTIVE STUDIES; THROMBOSIS; WHOLE BLOOD COAGULATION TIME; YOUNG ADULT;

EID: 84900562634     PISSN: 15297535     EISSN: 19473893     Source Type: Journal    
DOI: 10.1097/PCC.0000000000000101     Document Type: Article

References (22)

1. Bartlett RH, Gazzaniga AB, Jefferies MR, et al: Extracorporeal membrane oxygenation (ECMO) cardiopulmonary support in infancy. Trans Am Soc Artif Intern Organs 1976; 22:80-93
2. Zapol WM, Snider MT, Hill JD, et al: Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA 1979; 242:2193-2196 (Pubitemid 10195729)
3. Bartlett RH, Roloff DW, Cornell RG, et al: Extracorporeal circulation in neonatal respiratory failure: A prospective randomized study. Pediatrics 1985; 76:479-48
4. Bembea MM, Annich G, Rycus P, et al: Variability in anticoagulation management of patients on extracorporeal membrane oxygenation: An international survey. Pediatr Crit Care Med 2013; 14:e77-84
5. Green TP, Isham-Schopf B, Steinhorn RH, et al: Whole blood activated clotting time in infants during extracorporeal membrane oxygenation. Crit Care Med 1990; 18:494-498 (Pubitemid 20164870)
6. Bull BS, Huse WM, Brauer FS, et al: Heparin therapy during extracorporeal circulation. II. The use of a dose-response curve to individualize heparin and protamine dosage. J Thorac Cardiovasc Surg 1975; 69:685-689
7. Graves DF, Chernin JM, Kurusz M, et al: Anticoagulation practices during neonatal extracorporeal membrane oxygenation: Survey results. Perfusion 1996; 11:461-466 (Pubitemid 27007208)
8. Baird CW, Zurakowski D, Robinson B, et al: Anticoagulation and pediatric extracorporeal membrane oxygenation: Impact of activated clotting time and heparin dose on survival. Ann Thorac Surg 2007; 83:912-919; discussion 920
9. Bembea MM, Schwartz JM, Shah N, et al: Anticoagulation monitoring during pediatric extracorporeal membrane oxygenation. ASAIO J 2013; 59:63-68
10. Oliver WC: Anticoagulation and coagulation management for ECMO. Semin Cardiothorac Vasc Anesth 2009; 13:154-175
11. Nankervis CA, Preston TJ, Dysart KC, et al: Assessing heparin dosing in neonates on venoarterial extracorporeal membrane oxygenation. Asaio J 2007; 53:111-114 (Pubitemid 46145500)
12. Gorlinger K, Bergmann L, Dirkmann D: Coagulation management in patients undergoing mechanical circulatory support. Best Pract Res Clin Anaesthesiol 2012; 26:179-198
13. Reed RC, Rutledge JC: Laboratory and clinical predictors of thrombosis and hemorrhage in 29 pediatric extracorporeal membrane oxygenation nonsurvivors. Pediatr Dev Pathol 2010; 13:385-392
14. Maul TM, Wolff EL, Kuch BA, et al: Activated partial thromboplastin time is a better trending tool in pediatric extracorporeal membrane oxygenation. Pediatr Crit Care Med 2012; 13:e363-e371
15. Muntean W: Coagulation and anticoagulation in extracorporeal membrane oxygenation. Artif Organs 1999; 23:979-983
16. Sievert A, Uber W, Laws S, et al: Improvement in long-term ECMO by detailed monitoring of anticoagulation: A case report. Perfusion 2011; 26:59-64
17. Harris PA, Taylor R, Thielke R, et al: Research electronic data capture (REDCap) - a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42:377-381
18. Urlesberger B, Zobel G, Zenz W, et al: Activation of the clotting system during extracorporeal membrane oxygenation in term newborn infants. J Pediatr 1996; 129:264-268 (Pubitemid 27483799)
19. Adrian K, Skogby M, Friberg LG, et al: The effect of s- nitroso-glutathione on platelet and leukocyte function during experimental extracorporeal circulation. Artif Organs 2003; 27:570-575 (Pubitemid 36683658)
20. Stammers AH, Fristoe LW, Christensen K, et al: Coagulopathic- induced membrane dysfunction during extracorporeal membrane oxygenation: A case report. Perfusion 1997; 12:143-149 (Pubitemid 27212171)
21. Harrell FE: Regression Modeling Strategies. New York, NY, Springer, 2001
22. Nowak-Gottl U, Kosch A, Schlegel N: Neonatal thromboembolism. Semin Thromb Hemost 2003; 29:227-234